Similar articles

• Lack of altered cyclic nucleotide phosphodiesterase activity in the aorta and heart of the spontaneously hypertensive rat.

  Donnelly TE Jr. Donnelly TE Jr. Biochim Biophys Acta. 1978 Aug 17;542(2):245-52. doi: 10.1016/0304-4165(78)90020-x. Biochim Biophys Acta. 1978. PMID: 210834
• A reverse-phase HPLC method for cyclic nucleotide phosphodiesterases activity and classification.

  Spoto G, Berardi S, Ajerba G, De Laurentiis V. Spoto G, et al. Adv Exp Med Biol. 1994;370:815-20. doi: 10.1007/978-1-4615-2584-4_171. Adv Exp Med Biol. 1994. PMID: 7661030 No abstract available.
• Cyclic 3':5'-nucleotide phosphodiesterase determined in various human tissues by DEAE-cellulose chromatography.

  Hidaka H, Yamaki T, Ochiai Y, Asano T, Yamabe H. Hidaka H, et al. Biochim Biophys Acta. 1977 Oct 13;484(2):398-407. doi: 10.1016/0005-2744(77)90095-x. Biochim Biophys Acta. 1977. PMID: 199262
• [Modern representations of multiple forms of cyclic nucleotide phosphodiesterases in mammalian tissues].

  Medvedeva MV. Medvedeva MV. Biokhimiia. 1995 Mar;60(3):364-86. Biokhimiia. 1995. PMID: 7734612 Review. Russian.
• Cyclic-GMP-regulated enzymes and their possible physiological functions.

  Walter U. Walter U. Adv Cyclic Nucleotide Protein Phosphorylation Res. 1984;17:249-58. Adv Cyclic Nucleotide Protein Phosphorylation Res. 1984. PMID: 6145321 Review. No abstract available.